EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC-ND 4.0

Understanding the cervicovaginal immune response to Lactobacillus crispatus CTV-05

Michelle C Sabo, Javeed A Shah, Jennifer M Lund, R Scott McClelland

The Lancet Microbe · 2026-06 · 7 (6) · 101377

DOI: 10.1016/j.lanmic.2026.101377 ↗

Kurz gefasst

Leserbrief in der Zeitschrift The Lancet Microbe, 2026-06. Verfasst von Michelle C Sabo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Washington, Seattle 98104, WA, USA. Electronic address: sabo@uw.edu. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We enjoyed reading the Article by Anke Hemmerling and colleagues published in The Lancet Microbe.1 The presentation of randomised trial data addressing key questions on the relationship between vaginal microbiota and HIV susceptibility in women is valuable. In reviewing the Article, we noted a few points that would benefit from clarification by Hemmerling and colleagues. From the ClinicalTrials.gov submission for this trial (NCT05022212), the authors identified the primary outcome as a change in the number and proportion of endocervical HIV target cells, defined as CD4+ CD38+ HLA-DR+ CCR5+ cells, at day 64 of the study but did not define the denominator for the proportion of CCR5+ CD4+ T cells.

Autor:innen und Institutionen

  • Department of Medicine, University of Washington, Seattle 98104, WA, USA. Electronic address: sabo@uw.edu.
  • Department of Medicine, University of Washington, Seattle 98104, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA; VA Puget Sound Healthcare System, Seattle, WA, USA.
  • Department of Global Health, University of Washington, Seattle, WA, USA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Department of Medicine, University of Washington, Seattle 98104, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA;…

Zitieren

APA

Sabo, M. C., Shah, J. A., Lund, J. M., & McClelland, R. S. (2026). Understanding the cervicovaginal immune response to Lactobacillus crispatus CTV-05. The Lancet Microbe, 7(6), 101377. https://doi.org/10.1016/j.lanmic.2026.101377

Vancouver

Sabo MC, Shah JA, Lund JM, McClelland RS. Understanding the cervicovaginal immune response to Lactobacillus crispatus CTV-05. The Lancet Microbe. 2026;7(6):101377. doi:10.1016/j.lanmic.2026.101377

BibTeX
@article{Sabo2026,
  author = {Sabo, Michelle C and Shah, Javeed A and Lund, Jennifer M and McClelland, R Scott},
  title = {Understanding the cervicovaginal immune response to Lactobacillus crispatus CTV-05},
  journal = {The Lancet Microbe},
  year = {2026},
  volume = {7},
  number = {6},
  pages = {101377},
  doi = {10.1016/j.lanmic.2026.101377}
}
Kostenlos starten →